According to IMARC Group’s latest report, titled “United States Platelet Rich Plasma Market Analysis: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the United States platelet rich plasma market grew at a CAGR of around 10% during 2015-2020. Looking forward, the market is expected to continue its strong growth during the next five years.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Platelet-rich plasma (PRP) refers to concentrated plasma proteins that consist of red blood cells (RBCs). It is commonly administered in the patient’s body by minimally invasive procedures to assist in the rejuvenation of muscle fibers and ligaments.
Request Free Sample Report: https://www.imarcgroup.com/united-states-platelet-rich-plasma-market/requestsample
The market in the United States (US) is majorly driven by the increasing incidences of chronic tendon injuries in vital organs. Coupled with the growing utilization of effective therapies for the treatment of arthritis, fractures, orthopedic impairments and acute ligament tear, this is providing an impetus to the market growth. Apart from this, there has been a considerable rise in the deployment of advanced healthcare facilities across sports clubs and schools in the country for treating common injuries among athletes, which is creating a positive outlook for the market. Some of the other factors contributing to the market growth include the escalating preference for non-invasive medical procedures, the growing deployment of PRP-based procedures in cosmetic surgery and the expanding healthcare spending in the US.
Ask Analyst and Browse Full Report with TOC & List of Figure:
List of Key Companies Covered in this Market Report:
- Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
- Arthrex Inc.
- Depuy Synthes Inc. (Johnson & Johnson)
- Dr Prp USA LLC
- EmCyte Corporation
- Exactech Inc.
- Glofinn America LLC (Glofinn Co. Ltd.)
- Regen Lab USA LLC
- Stryker Corporation
- Terumo BCT Inc. (Terumo Corporation)
- ThermoGenesis Holdings Inc.
- Zimmer Biomet Holdings Inc.
The report has segmented the market on the basis of product type, origin, application, end user and region.
Breakup by Product Type:
- Pure Platelet-Rich Plasma (P-PRP)
- Leukocyte- and Platelet-Rich Plasma (LPRP)
- Leukocyte- and Platelet-Rich Fibrin (L-PRF)
- Pure Platelet-Rich Fibrin (P-PRF)
Breakup by Origin:
- Autologous PRP
- Homologous PRP
- Allogeneic PRP
Breakup by Application:
- Cosmetic Surgery and Dermatology
- General Surgery
- Cardiothoracic Surgery
Breakup by End User:
- Hospitals and Clinics
- Research Institutes
Breakup by Region:
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Follow us on Twitter: https://twitter.com/ImarcServices